India nowhere in the top COVID-19 clinical study hotspots; US, France and Italy at top 3 spots

<h1 style=India nowhere in the top COVID-19 clinical study hotspots; US, France and Italy at top 3 spots" class="background-image-source">

India, despite its dubious distinction of being the seventh most affected countries, is spotted nowhere close to the top ten locations in the world as far as the number of clinical studies to understand novel coronavirus is concerned. A recent clinical study projects aggregated data, compiled by Finbold.com —Finbold.com in-house aggregated data shows that ten countries are currently conducting 1,141 Covid-19 related clinical studies as part of global initiative to test and understand the COVID-19 pandemic.It also include the studies to develop effective therapies and vaccines against the infection.

The index has identified the United States as the leading country with Covid-19 clinical studies at 335. France comes second with 274 studies followed by Italy at 87 studies. Spain is fourth with 86 studies while China closes the top five categories with 78 clinical studies.

The United Kingdom occupies the sixth spot with 73 clinical studies followed by Germany at 55. Other countries with leading studies include Canada (54), Egypt (44), and Turkey (35).

Currently, the Coronavirus cases are at least 6.3 million globally with the United States leading with about 1.85 million infections. India, with 2,07,615 infection cases, is currently the seventh worst-hit country as on June, 2. The other most affected countries after US include Brazil, Russia, Spain, UK and Italy.